[{"Assets_0_Q1_USD":143541000.0,"CommonStockSharesOutstanding_0_Q1_shares":31663701.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-13582000.0,"NetIncomeLoss_1_Q1_USD":-9508000.0,"StockholdersEquity_0_Q1_USD":130152000.0,"Ticker":"REPL","CIK":"1737953","name":"REPLIMUNE GROUP, INC.","OfficialName":"Replimune Group Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"857797433.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190814"}]